ストックスクリーナーアプリを入手
1.42
2.16%
0.03
プレマーケット:
1.43
0.01
+0.70%
前日終値:
$1.39
開ける：
$1.38
24時間の取引高:
4.66M
Relative Volume:
0.53
時価総額：
$426.12M
収益：
$188.87M
当期純損益:
$-400.38M
株価収益率:
-0.9467
EPS:
-1.5
ネットキャッシュフロー:
$-260.90M
1週間 パフォーマンス:
-7.79%
1か月 パフォーマンス:
-11.25%
6か月 パフォーマンス:
-13.41%
1年 パフォーマンス:
-8.09%
1日の値動き範囲:
$1.3611
$1.44
1週間の範囲:
$1.29
$1.60
52週間の値動き範囲:
$0.8511
$2.72
Pacific Biosciences Of California Inc Stock (PACB) Company Profile
名前
Pacific Biosciences Of California Inc
セクター
電話
650-521-8000
住所
1305 O'BRIEN DRIVE, MENLO PARK, CA
PACB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PACB
Pacific Biosciences Of California Inc
|
1.42 | 417.12M | 188.87M | -400.38M | -260.90M | -1.50 |
|
ABT
Abbott Laboratories
|
130.69 | 226.14B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.83 | 158.24B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
380.86 | 145.85B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
89.67 | 114.85B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.24 | 46.98B | 5.69B | 4.15B | 623.10M | 6.95 |
Pacific Biosciences Of California Inc Stock (PACB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-11 | ダウングレード | UBS | Buy → Neutral |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-22 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-04-18 | ダウングレード | Goldman | Buy → Neutral |
| 2023-12-14 | 開始されました | Guggenheim | Neutral |
| 2023-12-14 | 開始されました | Stephens | Overweight |
| 2023-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2023-11-17 | アップグレード | UBS | Neutral → Buy |
| 2023-10-31 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-06-30 | 開始されました | Goldman | Buy |
| 2023-05-10 | 開始されました | Barclays | Equal Weight |
| 2023-03-31 | アップグレード | TD Cowen | Market Perform → Outperform |
| 2023-02-02 | 開始されました | UBS | Neutral |
| 2023-01-20 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
| 2022-01-21 | 再開されました | Cantor Fitzgerald | Overweight |
| 2022-01-06 | 再開されました | Piper Sandler | Neutral |
| 2021-10-15 | 再開されました | Cowen | Market Perform |
| 2021-09-27 | 開始されました | Canaccord Genuity | Buy |
| 2021-02-11 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2020-11-03 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-10-02 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-09-09 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-06-02 | 再開されました | Cantor Fitzgerald | Overweight |
| 2020-03-09 | 再開されました | Cantor Fitzgerald | Overweight |
| 2019-10-15 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2019-04-02 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2018-10-19 | 開始されました | Cowen | Outperform |
| 2017-11-03 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-28 | ダウングレード | CL King | Buy → Neutral |
| 2016-11-03 | 繰り返されました | Cantor Fitzgerald | Buy |
| 2016-06-27 | 開始されました | CL King | Buy |
| 2016-04-15 | 開始されました | First Analysis Sec | Overweight |
| 2016-02-04 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2016-01-04 | 繰り返されました | Cantor Fitzgerald | Buy |
| 2015-10-23 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2015-08-27 | 開始されました | Cantor Fitzgerald | Buy |
| 2015-02-04 | 繰り返されました | Maxim Group | Buy |
| 2013-09-26 | 繰り返されました | Maxim Group | Buy |
| 2013-01-14 | 繰り返されました | Maxim Group | Buy |
すべてを表示
Pacific Biosciences Of California Inc (PACB) 最新ニュース
PacBio (PACB) Q2 Earnings Report Preview: What To Look For - Yahoo Finance
Pacific Biosciences of California Inc expected to post a loss of 17 cents a shareEarnings Preview - TradingView
Will Pacific Biosciences of California Inc. Reverse From Oversold ConditionsChart Driven High Reward Trading Setup Presented - beatles.ru
Stay Ahead of the Game With Pacific Biosciences (PACB) Q2 Earnings: Wall Street's Insights on Key Metrics - Yahoo Finance
PacBio and Collaborators Release Landmark Platinum Pedigree Dataset, Enhancing Genomic Variant Accuracy by 34% With AI Integration - Quiver Quantitative
Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models - Yahoo Finance
How strong is Pacific Biosciences of California Inc. company’s balance sheetGet expert advice on portfolio optimization - Jammu Links News
When is Pacific Biosciences of California Inc. stock expected to show significant growthOutstanding capital returns - Jammu Links News
What catalysts could drive Pacific Biosciences of California Inc. stock higher in 2025Invest smarter with expert trading signals - Jammu Links News
Should I hold or sell Pacific Biosciences of California Inc. stock in 2025Superior risk-adjusted returns - Jammu Links News
How does Pacific Biosciences of California Inc. generate profit in a changing economyAchieve rapid wealth accumulation with smart picks - Jammu Links News
What institutional investors are buying Pacific Biosciences of California Inc. stockUnprecedented profits - Jammu Links News
What are Pacific Biosciences of California Inc. company’s key revenue driversBuild a diversified portfolio for steady growth - Jammu Links News
What is Pacific Biosciences of California Inc. company’s growth strategyExponential return rates - Jammu Links News
Is Pacific Biosciences of California Inc. a growth stock or a value stockAccess high-yield investment alerts now - Jammu Links News
What are analysts’ price targets for Pacific Biosciences of California Inc. in the next 12 monthsLightning-fast growth - Jammu Links News
Published on: 2025-08-03 06:22:09 - Jammu Links News
What is the dividend policy of Pacific Biosciences of California Inc. stockBuild a portfolio that delivers consistent profits - Jammu Links News
How Pacific Biosciences of California Inc. stock performs during market volatilityLow Risk Picks for Daily Trading Released - beatles.ru
Options Data Show Bullish Bias in Pacific Biosciences of California Inc.Conservative Long Term Growth Plans Under Review - metal.it
Does Pacific Biosciences of California Inc. stock perform well during market downturnsFinancial News Target Finder For Smart Trading - jammulinksnews.com
Customer success story: How Dr. Ibrahim Bitar is doubling his research impact while leading the future of European genomics from the Czech Republic - PacBio
Pacific Biosciences (PACB) Jumps 6.5% Ahead of Earnings - MSN
Here's Why You Should Add PacBio Stock to Your Portfolio Now - MSN
What makes Pacific Biosciences of California Inc. stock price move sharplyPattern Breakout Entry Stock Forecast in Focus - metal.it
Pacific Biosciences of California (PACB) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
PacBio, 10x Genomics, QuidelOrtho, STAAR Surgical, and Clover Health Stocks Trade Down, What You Need To Know - Yahoo Finance
Pacific Biosciences Soars 6.5% Pre-Earnings Amid Restructuring Hopes - AInvest
Even after rising 13% this past week, Pacific Biosciences of California (NASDAQ:PACB) shareholders are still down 63% over the past three years - Yahoo Finance
Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing - MarketScreener
Is Pacific Biosciences of California (NASDAQ:PACB) A Risky Investment? - simplywall.st
Wyckoff Accumulation Phase Possible in Pacific Biosciences of California Inc.Entry Points For Growing Stocks Identified by Models - metal.it
These 10 Stocks are Winning Big - Insider Monkey
Is it the right time to buy Pacific Biosciences of California Inc. stockBuild a winning investment portfolio - Jammu Links News
Why is Pacific Biosciences of California Inc. stock attracting strong analyst attentionBuild wealth steadily with smart stock selection - jammulinksnews.com
Pacific Biosciences Of California Inc (PACB) 財務データ
収益
当期純利益
現金流量
EPS
Pacific Biosciences Of California Inc (PACB) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| HENRY CHRISTIAN O | See Remarks |
Mar 03 '25 |
Sale |
1.41 |
12,497 |
17,583 |
2,225,357 |
| Van Oene Mark | See Remarks |
Mar 03 '25 |
Sale |
1.41 |
6,486 |
9,126 |
1,497,695 |
| Farmer Michele | See Remarks |
Mar 03 '25 |
Sale |
1.41 |
2,973 |
4,183 |
184,619 |
2.35%
0.14%
大文字化:
|
ボリューム (24 時間):